Response to the Letter to the Editor Regarding “Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies” [Response to Letter]

Abstract

Thomas P Lodise,1 Sanjay Sethi2 1Department of Pharmacy Practice, Albany College Pharmacy and Health Sciences, Albany, NY, USA; 2Department of Medicine, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, USACorrespondence: Sanjay SethiClinical and Translational Research Center, 875 Ellicott St., Room 6045A, Buffalo, NY, 14215, USAEmail [email protected] View the original paper by Lodise and colleagues   This is in response to the Letter to the Editor